These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31164251)

  • 1. Re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting Functional Outcomes After Partial and Radical Nephrectomy. Eur Urol 2019;75:766-72: Partial Nephrectomy: "Geocentrism" of the 21st century in the Church of Urology?
    Takahashi T
    Eur Urol; 2019 Sep; 76(3):e65-e66. PubMed ID: 31164251
    [No Abstract]   [Full Text] [Related]  

  • 2. Reply to Takeshi Takahashi's Letter to the Editor re: Bimal Bhindi, Christine M. Lohse, Phillip J. Schulte, et al. Predicting functional outcomes after partial and radical nephrectomy. Eur Urol 2019;75:766-72. Partial Nephrectomy: "Geocentrism" of the 21st century in the Church of Urology?
    Bhindi B; Lohse CM; Schulte PJ; Mason RJ; Cheville JC; Boorjian SA; Leibovich BC; Thompson RH
    Eur Urol; 2019 Sep; 76(3):e67-e68. PubMed ID: 31167750
    [No Abstract]   [Full Text] [Related]  

  • 3. Re: Bimal Bhindi, Jeffrey Graham, J. Connor Wells, et al. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.038: Cytoreductive Nephrectomy: To Whom and When?
    Mollica V; Rizzo A; Massari F
    Eur Urol Oncol; 2020 Aug; 3(4):559-560. PubMed ID: 32553708
    [No Abstract]   [Full Text] [Related]  

  • 4. Re: Bimal Bhindi, E. Jason Abel, Laurence Albiges, et al. Systematic Review of the Role of Cytoreductive Nephrectomy in the Targeted Therapy Era and Beyond: An Individualized Approach to Metastatic Renal Cell Carcinoma. Eur Urol 2019;75:111-28: Cytoreductive Nephrectomy in the Targeted Therapy Era: This is Not the End.
    Massari F; Di Nunno V; Santoni M; Gatto L; Mollica V; Porta C
    Eur Urol Oncol; 2019 Sep; 2(5):603-604. PubMed ID: 31411982
    [No Abstract]   [Full Text] [Related]  

  • 5. Re: Carlo Bravi, Emily Vertosick, Nicole Benfante, et al. Impact of Acute Kidney Injury and Its Duration on Long-term Renal Function After Partial Nephrectomy. Eur Urol 2019;76:398-403.
    Kim WH; Yoon HK; Jeong CW
    Eur Urol; 2020 Jan; 77(1):e14-e15. PubMed ID: 31586511
    [No Abstract]   [Full Text] [Related]  

  • 6. Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31: Should Chromophobe Renal Cell Carcinoma Be Graded?
    Delahunt B; Samaratunga H; Egevad L
    Eur Urol; 2021 May; 79(5):e141-e142. PubMed ID: 33612375
    [No Abstract]   [Full Text] [Related]  

  • 7. Re: Paul C.M.S. Verhagen, Egbert R. Boevé. The European Association of Urology Guideline on Renal Cell Carcinoma (RCC) is Not Concise in its Recommendation to Perform Partial Nephrectomy in T1b RCC. Eur Urol 2019:76:136-7.
    Marconi L; Bensalah K; Bex A;
    Eur Urol; 2019 Jul; 76(1):e12-e13. PubMed ID: 30922689
    [No Abstract]   [Full Text] [Related]  

  • 8. Reply to Lorenzo Marconi, Karim Bensalah, and Axel Bex's Letter to the Editor re: Paul C.M.S. Verhagen, Egbert R. Boevé. The European Association of Urology Guideline on Renal Cell Carcinoma (RCC) is Not Concise in its Recommendation to Perform Partial Nephrectomy in T1b RCC. Eur Urol 2019;76:136-7.
    Verhagen PCMS; Boevé ER
    Eur Urol; 2019 Jul; 76(1):e14. PubMed ID: 30910344
    [No Abstract]   [Full Text] [Related]  

  • 9. Re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31: Two-, Three-, or Four-tiered Grading of Chromophobe Renal Cancer: That's the Question!
    Ohashi R; Hartmann A; Martignoni G; Moch H
    Eur Urol; 2021 Jul; 80(1):e17-e18. PubMed ID: 33934927
    [No Abstract]   [Full Text] [Related]  

  • 10. Re: Outcomes following partial nephrectomy by tumor size P. L. Crispen, S. A. Boorjian, C. M. Lohse, T. S. Sebo, J. C. Cheville, M. L. Blute and B. C. Leibovich J Urol 2008; 180: 1912-1917.
    Cimen HI; Serefoglu EC; Balbay MD
    J Urol; 2009 Sep; 182(3):1232; author reply 1232. PubMed ID: 19625039
    [No Abstract]   [Full Text] [Related]  

  • 11. Re: Riccardo Campi, Riccardo Bertolo, Andrea Minervini, European Association of Urology Young Academic Urologists Renal Cancer Working Group. Re: Partial Versus Radical Nephrectomy in Clinical T2 Renal Masses. Klett DE, Tsivian M, Packiam VT, et al. Int J Urol. 2021;28:1149-54. Eur Urol. 2021;80:760-2: Partial Nephrectomy for T2 Kidney Cancer Might Violate the Declaration of Helsinki.
    Takahashi T
    Eur Urol; 2022 Feb; 81(2):e44-e45. PubMed ID: 34887116
    [No Abstract]   [Full Text] [Related]  

  • 12. Reply to Takeshi Takahashi's Letter to the Editor re: Riccardo Campi, Riccardo Bertolo, Andrea Minervini, European Association of Urology Young Academic Urologists Renal Cancer Working Group. Re: Partial Versus Radical Nephrectomy in Clinical T2 Renal Masses. Klett DE, Tsivian M, Packiam VT, et al. Int J Urol. 2021;28:1149-54. Eur Urol 2021;80;760-2. Partial Nephrectomy for T2 Kidney Cancer Might Violate the Declaration of Helsinki: Re-envisioning the Value of Clinical Research to Foster the Progress of Evidence-based Urology: The Case of Partial Nephrectomy for cT2 Renal Masses.
    Campi R; Bertolo R; Minervini A;
    Eur Urol; 2022 Feb; 81(2):e46-e47. PubMed ID: 34887115
    [No Abstract]   [Full Text] [Related]  

  • 13. Reply to Riuko Ohashi, Arndt Hartmann, Holger Moch, and Guido Martignoni's Letter to the Editor re: Svetlana Avulova, John C. Cheville, Christine M. Lohse, et al. Grading of Chromophobe Renal Cell Carcinoma: Evidence for a Four-tiered Classification Incorporating Coagulative Tumor Necrosis. Eur Urol 2021;79:225-31: Two-, Three-, or Four-tiered Grading of Chromophobe Renal Cancer: That's the Question!
    Avulova S; Cheville JC; Lohse CM; Thompson RH; Potretzke AM
    Eur Urol; 2021 Jul; 80(1):e19. PubMed ID: 33875305
    [No Abstract]   [Full Text] [Related]  

  • 14. Re: Editorial Comment from Dr Bertolo et al. to Partial nephrectomy preserves renal function without increasing the risk of complications compared with radical nephrectomy for renal cell carcinomas of stages pT2-3a.
    Mühlbauer J; Kowalewski KF; Kriegmair MC
    Int J Urol; 2021 Jan; 28(1):133. PubMed ID: 33135222
    [No Abstract]   [Full Text] [Related]  

  • 15. Re: outcome of stage T2 or greater renal cell cancer treated with partial nephrectomy: R. H. Breau, P. L. Crispen, R. E. Jimenez, C. M. Lohse, M. L. Blute and B. C. Leibovich J Urol 2010; 183: 903-908.
    Cimen HI; Canda AE; Balbay MD
    J Urol; 2010 Nov; 184(5):2212; author reply 2212-3. PubMed ID: 20864129
    [No Abstract]   [Full Text] [Related]  

  • 16. Re: An et al.: Partial vs Radical Nephrectomy for T1-T2 Renal Masses in the Elderly: Comparison of Complications, Renal Function, and Oncologic Outcomes (Urology 2017;100:151-157).
    Panaiyadiyan S; Kumar R
    Urology; 2017 May; 103():274. PubMed ID: 28237531
    [No Abstract]   [Full Text] [Related]  

  • 17. Editorial Comment from Dr Bertolo et al. to Partial nephrectomy preserves renal function without increasing the risk of complications compared with radical nephrectomy for renal cell carcinomas of stages pT2-3a.
    Bertolo R; Cipriani C; Ferro M; Bove P
    Int J Urol; 2020 Oct; 27(10):914. PubMed ID: 32783281
    [No Abstract]   [Full Text] [Related]  

  • 18. Re: Hiury S. Andrade, Homayoun Zargar, Peter A. Caputo, et al. Five-year Oncologic Outcomes After Transperitoneal Robotic Partial Nephrectomy for Renal Cell Carcinoma. Eur Urol 2016;69:1149-54.
    Shin TY; Abdel Raheem A; Rha KH
    Eur Urol; 2016 Oct; 70(4):e100-e101. PubMed ID: 26995331
    [No Abstract]   [Full Text] [Related]  

  • 19. Re: Maxine Sun, Quoc-dien Trinh, Marco Bianchi, et al. A non-cancer-related survival benefit is associated with partial nephrectomy. Eur Urol 2012;61:725-31.
    Sandhu GS; Tanagho YS; Bhayani SB
    Eur Urol; 2012 Sep; 62(3):e58; author reply e59-60. PubMed ID: 22704368
    [No Abstract]   [Full Text] [Related]  

  • 20. Re: R. Houston Thompson, Tom Atwell, Grant Schmit, et al. Comparison of partial nephrectomy and percutaneous ablation for cT1 renal masses. Eur Urol 2015;67:252-9.
    Potretzke AM; Larson JA; Bhayani SB
    Eur Urol; 2015 Feb; 67(2):e19-20. PubMed ID: 25269382
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.